TAK stock icon

Takeda Pharmaceutical
TAK

$13.70
3.01%

Market Cap: 43.4B

 

About: Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

Employees: 49,281

0
Funds holding %
of 6,702 funds
Analysts bullish %
0
News positive %
of 9 articles

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

1,417% more call options, than puts

Call options by funds: $26.1M | Put options by funds: $1.72M

38% more repeat investments, than reductions

Existing positions increased: 113 | Existing positions reduced: 82

5% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 37

1% more funds holding

Funds holding: 300 [Q4 2023] → 302 (+2) [Q1 2024]

0.33% less ownership

Funds ownership: 5.26% [Q4 2023] → 4.93% (-0.33%) [Q1 2024]

9% less capital invested

Capital invested by funds: $1.19B [Q4 2023] → $1.08B (-$107M) [Q1 2024]

80% less funds holding in top 10

Funds holding in top 10: 5 [Q4 2023] → 1 (-4) [Q1 2024]

Research analyst outlook

We haven’t received any recent analyst ratings for TAK.

Financial journalist opinion

Based on 9 articles about TAK published over the past 30 days